New data from the federal Centers for Disease Control and Prevention indicate Oklahoma’s obesity rate is declining. CDC data showed the state’s adult obesity rates dropping from 38.7% to 36.8% between ...

As both Novo Nordisk and Eli Lilly race to develop their long-anticipated oral GLP-1 obesity meds, a new report shows one taking a clear lead among potential prescribers. Spherix Global Insights ...

Public trust in the media and in data has been undercut by information overload, relentless social media cycles, and targeted influence campaigns. Whether driven by politics, social movements, or ...

Editor's note: This article was updated at 430p to reflect Monday's closing gain. Wave Life Sciences (WVE) closed Monday up ~147% after reporting that a single 240 mg dose of its experimental obesity ...

Amid an outpouring of obesity data Monday, Wave Life Sciences and Structure Therapeutics were among the biotechs jockeying to set their weight loss assets apart in an increasingly crowded field as ...

Advanced data visualization and analytics have become central to enterprise IT strategies as organizations face rapid data growth from cloud services, software-as-a-service applications, edge devices, ...

The World Health Organization (WHO) released its first-ever guideline on using GLP-1 medications to treat obesity. The disease now affects more than 1 billion people worldwide and is tied to 3.7 ...

RBC Capital Markets upgraded Neumora Therapeutics, Inc. (NASDAQ: NMRA) from Sector Perform to Outperform, with an increased price forecast from $4 to $7. The company is evolving beyond neurology and ...

*America’s struggle with rising obesity may be reaching a turning point. After years of unsuccessful interventions—from government health campaigns to commercial diet programs—new survey data hints at ...